Journal of General Internal Medicine

, Volume 24, Issue 2, pp 263–269 | Cite as

Patterns and Determinants of Inappropriate Antibiotic Use in Injection Drug Users

  • Joanna L. Starrels
  • Frances K. Barg
  • Joshua P. Metlay
Populations at Risk

Abstract

Background

Inappropriate antibiotic use contributes to the emergence and spread of drug resistant infections. Though injection drug users are at increased risk for drug resistant infections, few studies have examined antibiotic use in this population.

Objective

To understand patterns and determinants of antibiotic use among injection drug users.

Methods

Five focus groups were conducted with 28 current injection drug users recruited from a syringe exchange program in Philadelphia and analyzed using the constant comparative method to identify emergent themes. Twenty-six participants also completed a written survey instrument.

Results

Injection drug users reported frequent antibiotic exposure, with 12 of 26 participants reporting use of antibiotic medications at least once in the previous 30 days. Participants reported several patterns of antibiotic use that were potentially harmful, including delays in seeking medical care, failing to fill prescriptions, obtaining antibiotics from non-provider sources, and poor adherence to prescribed regimens. The major determinants of inappropriate antibiotic use were delayed recognition of severity of illness, reluctance to wait to be seen, previous mistreatment by providers, lack of insurance, prioritizing purchasing drugs of abuse over antibiotics, forgetting to take antibiotics because of distractions that accompany drug use, concerns about interactions between antibiotics and other substances, and an irregular diet. Additionally, injection drug users commonly misunderstood the concept of antibiotic resistance and equated it with tolerance.

Conclusions

Injection drug users reported potentially dangerous antibiotic use behaviors and described determinants of these behaviors. Outreach and educational interventions to improve antibiotic use should target high-risk populations, such as injection drug users, and consider their distinct antibiotic use behaviors and determinants.

KEY WORDS

antibiotics adherence injection drug use self-medication 

Notes

Acknowledgements

The authors would like to thank Katrina Armstrong, MD, MS, and Sandy Schwartz, MD, for conceptual development; Caitlin Loomis, Emily Mannes, and A. Robinson Williams for research assistance; Casey Cook, Melanie Sisemore, and others at Prevention Point Philadelphia; and the study participants. This project was supported by a pilot grant from the Leonard Davis Institute for Health Economics at the University of Pennsylvania. Additional support was provided by the Department of Veterans Affairs and the Robert Wood Johnson Foundation Clinical Scholars Program. This project was previously presented at the Robert Wood Johnson Foundation Clinical Scholars Program national meeting on November 2, 2006 and the Society of General Internal Medicine annual meeting on April 11, 2008.

Conflict of Interest

None disclosed.

References

  1. 1.
    Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Med. 2006;119(6 Suppl 1):S3–10. discussion S62-70.CrossRefPubMedGoogle Scholar
  2. 2.
    World Health Organization. Drug resistance threatens to reverse medical progress. Press Release. 2000;41.Google Scholar
  3. 3.
    Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet. 2006;368(9538):874–85.CrossRefPubMedGoogle Scholar
  4. 4.
    Kunin CM. Resistance to antimicrobial drugs–a worldwide calamity. Ann Intern Med. 1993;118(7):557–61.PubMedGoogle Scholar
  5. 5.
    Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis. 2003;9(11):1415–22.PubMedGoogle Scholar
  6. 6.
    Gonzales R, Wilson A, Crane LA, Barrett PH Jr. What’s in a name? Public knowledge, attitudes, and experiences with antibiotic use for acute bronchitis. Am J Med. 2000;108(1):83–5.CrossRefPubMedGoogle Scholar
  7. 7.
    Corbett KK, Gonzales R, Leeman-Castillo BA, Flores E, Maselli J, Kafadar K. Appropriate antibiotic use: variation in knowledge and awareness by Hispanic ethnicity and language. Prev Med. 2005;40(2):162–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Mangione-Smith R, McGlynn EA, Elliott MN, McDonald L, Franz CE, Kravitz RL. Parent expectations for antibiotics, physician-parent communication, and satisfaction. Arch Pediatr Adolesc Med. 2001;155(7):800–6.PubMedGoogle Scholar
  9. 9.
    Gonzales R, Corbett KK, Leeman-Castillo BA, et al. The “minimizing antibiotic resistance in Colorado” project: impact of patient education in improving antibiotic use in private office practices. Health Serv Res. 2005;40(1):101–16.CrossRefPubMedGoogle Scholar
  10. 10.
    Steinman MA, Ranji SR, Shojania KG, Gonzales R. Improving antibiotic selection: a systematic review and quantitative analysis of quality improvement strategies. Med Care. 2006;44(7):617–28.CrossRefPubMedGoogle Scholar
  11. 11.
    Metlay JP, Camargo CA Jr., MacKenzie T, et al. Cluster-randomized trial to improve antibiotic use for adults with acute respiratory infections treated in emergency departments. Ann Emerg Med. 2007;50(3):221–30.CrossRefPubMedGoogle Scholar
  12. 12.
    Allison DC, Miller T, Holtom P, Patzakis MJ, Zalavras CG. Microbiology of upper extremity soft tissue abscesses in injecting drug abusers. Clin Orthop Relat Res. 2007;461:9–13.PubMedGoogle Scholar
  13. 13.
    Miller M, Cespedes C, Vavagiakis P, Klein RS, Lowy FD. Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur J Clin Microbiol Infect Dis. 2003;22(8):463–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Charlebois ED, Bangsberg DR, Moss NJ, et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis. 2002;34(4):425–33.CrossRefPubMedGoogle Scholar
  15. 15.
    Charlebois ED, Perdreau-Remington F, Kreiswirth B, et al. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2004;39(1):47–54.CrossRefPubMedGoogle Scholar
  16. 16.
    Saravolatz LD, Markowitz N, Arking L, Pohlod D, Fisher E. Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak. Ann Intern Med. 1982;96(1):11–6.PubMedGoogle Scholar
  17. 17.
    Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352(14):1445–53.CrossRefPubMedGoogle Scholar
  18. 18.
    Pan ES, Diep BA, Charlebois ED, et al. Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus–and their relation to community-associated disease activity. J Infect Dis. 2005;192(5):811–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Huang H, Cohen SH, King JH, Monchaud C, Nguyen H, Flynn NM. Injecting drug use and community-associated methicillin-resistant Staphylococcus aureus infection. Diagn Microbiol Infect Dis. 2008;60(4):347–50.PubMedGoogle Scholar
  20. 20.
    Cherubin CE, Sapira JD. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later.[see comment]. Ann Intern Med. 1993;119(10):1017–28.PubMedGoogle Scholar
  21. 21.
    Gordon RJ, Lowy FD. Bacterial infections in drug users. N Engl J Med. 2005;353(18):1945–54.CrossRefPubMedGoogle Scholar
  22. 22.
    Centers for Disease Control and Prevention. Soft tissue infections among injection drug users– San Francisco, California, 1996-2000. MMWR. 2001;50:381–4.Google Scholar
  23. 23.
    Spijkerman IJ, van Ameijden EJ, Mientjes GH, Coutinho RA, van den Hoek A. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol. 1996;49(10):1149–54.CrossRefPubMedGoogle Scholar
  24. 24.
    Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis. 2000;30(3):579–81.CrossRefPubMedGoogle Scholar
  25. 25.
    Paydar KZ, Hansen SL, Charlebois ED, Harris HW, Young DM. Inappropriate antibiotic use in soft tissue infections. Arch Surg. 2006;141(9):850–854. discussion 855-6.CrossRefPubMedGoogle Scholar
  26. 26.
    Lucas GM, Gebo KA, Chaisson RE, Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS. 2002;16(5):767–74.CrossRefPubMedGoogle Scholar
  27. 27.
    Carrieri MP, Chesney MA, Spire B, et al. Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users. Int J Behav Med. 2003;10(1):1–14.CrossRefPubMedGoogle Scholar
  28. 28.
    Arnsten JH, Demas PA, Grant RW, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002;17(5):377–81.PubMedGoogle Scholar
  29. 29.
    Howard AA, Arnsten JH, Lo Y, et al. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS. 2002;16(16):2175–82.CrossRefPubMedGoogle Scholar
  30. 30.
    Gebo KA, Keruly J, Moore RD. Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy. J Gen Intern Med. 2003;18(2):104–11.CrossRefPubMedGoogle Scholar
  31. 31.
    Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med. 2004;19(11):1111–7.CrossRefPubMedGoogle Scholar
  32. 32.
    Neale J, Allen D, Coombes L. Qualitative research methods within the addictions. Addiction. 2005;100(11):1584–93.CrossRefPubMedGoogle Scholar
  33. 33.
    Charmaz K. Grounded theory: objectivist and constructivist methods. In: Denzin NK, Lincoln YS, eds. Handbook of qualitative research. Thousand Oaks: Sage; 2000:509–35.Google Scholar
  34. 34.
    Glaser BG, Straus AL. The discovery of grounded theory: Strategies for qualitative research. New York: Aldine de Gruyter; 1999.Google Scholar
  35. 35.
    Boeje H. A purposeful approach to the constant comparative method in the analysis of qualitative interviews. Qual Quant. 2002;36:391–409.CrossRefGoogle Scholar
  36. 36.
    Vanden Eng J, Marcus R, Hadler JL, et al. Consumer attitudes and use of antibiotics. Emerg Infect Dis. 2003;9(9):1128–35.PubMedGoogle Scholar
  37. 37.
    Kardas P, Devine S, Golembesky A, Roberts C. A systematic review and meta-analysis of misuse of antibiotic therapies in the community. Int J Antimicrob Agents. 2005;26(2):106–13.CrossRefPubMedGoogle Scholar
  38. 38.
    Richman PB, Garra G, Eskin B, Nashed AH, Cody R. Oral antibiotic use without consulting a physician: a survey of ED patients. Am J Emerg Med. 2001;19(1):57–60.CrossRefPubMedGoogle Scholar
  39. 39.
    Porter J, Metzger D, Scotti R. Bridge to services: drug injectors’ awareness and utilization of drug user treatment and social service referrals, medical care, and HIV testing provided by needle exchange programs. Subst Use Misuse. 2002;37(11):1305–30.CrossRefPubMedGoogle Scholar
  40. 40.
    Neale J, Sheard L, Tompkins CNE. Factors that help injecting drug users to access and benefit from services: a qualitative study. Substance Abuse Treatment, Prevention, & Policy. 2007;2:31.CrossRefGoogle Scholar
  41. 41.
    Carbon C. Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci. J Antimicrob Chemother. 1999;44(Suppl A):31–6.CrossRefPubMedGoogle Scholar
  42. 42.
    Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36(1):53–9.CrossRefPubMedGoogle Scholar

Copyright information

© Society of General Internal Medicine 2008

Authors and Affiliations

  • Joanna L. Starrels
    • 1
    • 2
    • 3
    • 7
  • Frances K. Barg
    • 5
    • 6
  • Joshua P. Metlay
    • 1
    • 2
    • 3
    • 4
  1. 1.Robert Wood Johnson Clinical Scholars ProgramUniversity of Pennsylvania School of MedicinePhiladelphiaUSA
  2. 2.Veterans Affairs Medical CenterPhiladelphiaUSA
  3. 3.Leonard Davis Institute of Health EconomicsUniversity of PennsylvaniaPhiladelphiaUSA
  4. 4.Department of MedicineUniversity of Pennsylvania School of MedicinePhiladelphiaUSA
  5. 5.Department of AnthropologyUniversity of PennsylvaniaPhiladelphiaUSA
  6. 6.Department of Family Medicine and Community HealthUniversity of Pennsylvania School of MedicinePhiladelphiaUSA
  7. 7.Division of General Internal MedicineAlbert Einstein College of Medicine and Montefiore Medical CenterBronxUSA

Personalised recommendations